Related Experiment Video
Updated: Aug 5, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
SARS-CoV-2 ORF7a drives mitochondrial dysfunction via PDK4 activation and complex I inhibition
Raúl Fernández-Rodríguez1, Carmen M Soto-Jiménez1, Rebeca Acín-Pérez2
1Department of Genetics, Immunogenomics and Molecular Pathogenesis Group, UIC Zoonoses and Emergent Diseases ENZOEM, University of Córdoba (UCO), Córdoba, Spain; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection reprograms host metabolism to favor viral replication and immune evasion, yet the contribution of accessory proteins remains poorly defined. Here, we characterize the metabolic effects of the SARS-CoV-2 accessory protein ORF7a. Lentiviral expression of ORF7a in human lung epithelial (A549) and monocytic (THP1) cells, combined with integrated transcriptomic, proteomic, and metabolomic analyses, revealed marked dysregulation of glucose and lipid metabolism. ORF7a impaired mitochondrial oxidative phosphorylation, reducing basal and maximal respiration, inducing mitochondrial depolarization, and increasing reactive oxygen species. Mechanistically, ORF7a upregulated pyruvate dehydrogenase kinase 4 (PDK4), enhancing phosphorylation of the pyruvate dehydrogenase complex and suppressing pyruvate oxidation. However, pharmacological PDK4 inhibition failed to restore respiratory function. High-resolution respirometry identified complex I dysfunction, while Blue Native-PAGE revealed defective assembly of respiratory supercomplexes. Together, these findings demonstrate that ORF7a disrupts mitochondrial metabolism through enzymatic regulation and destabilization of the respiratory chain, highlighting mitochondria as a target of SARS-CoV-2-induced metabolic reprogramming.
Insights
The SARS-CoV-2 accessory protein ORF7a disrupts host cell metabolism. It impairs mitochondrial function by affecting glucose and lipid pathways, highlighting a new target for therapeutic intervention.
Area of Science:
- Cell Biology
- Virology
- Metabolic Research
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection alters host cell metabolism to support viral replication and immune evasion.
- The specific roles of SARS-CoV-2 accessory proteins, such as ORF7a, in metabolic reprogramming are not well understood.
Purpose of the Study:
- To investigate the metabolic impact of the SARS-CoV-2 accessory protein ORF7a.
- To elucidate the mechanisms by which ORF7a affects cellular metabolism, particularly mitochondrial function.
Main Methods:
- Lentiviral expression of ORF7a in human lung epithelial (A549) and monocytic (THP1) cells.
- Integrated transcriptomic, proteomic, and metabolomic analyses.
- High-resolution respirometry and Blue Native-PAGE to assess mitochondrial respiratory function and complex assembly.
Main Results:
- ORF7a significantly dysregulated glucose and lipid metabolism.
- Impaired mitochondrial oxidative phosphorylation, reduced respiration, mitochondrial depolarization, and increased reactive oxygen species were observed.
- ORF7a upregulated pyruvate dehydrogenase kinase 4 (PDK4), suppressing pyruvate oxidation, and caused complex I dysfunction and defective respiratory supercomplex assembly.
Conclusions:
- SARS-CoV-2 ORF7a protein disrupts mitochondrial metabolism through enzymatic regulation and destabilization of the respiratory chain.
- Mitochondria are a key target of SARS-CoV-2-induced metabolic reprogramming.
- ORF7a's effects on mitochondrial function present potential therapeutic targets.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
ATP Synthase: Mechanism
Mitochondrial Membranes
Mitochondrial Membranes
